mitoquinone

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• ADHD [Insufficient Evidence]
• age-related macular degeneration [Insufficient Evidence]
• aging [Insufficient Evidence]
• Alzheimer disease [Possibly Ineffective]
• amyotrophic lateral sclerosis [Possibly Ineffective]
• angina [Insufficient Evidence]
• anthracycline-induced cardiotoxicity [Insufficient Evidence]
• anxiety [Insufficient Evidence]
• asthma [Insufficient Evidence]
• athletic performance [Likely Ineffective]
• autism spectrum disorder [Insufficient Evidence]
• bipolar disorder [Insufficient Evidence]
• BPH [Insufficient Evidence]
• breast CA [Insufficient Evidence]
• burns [Insufficient Evidence]
• cancer [Insufficient Evidence]
• cardiac event prevention, post-MI [Possibly Effective]
• cardiomyopathy, dilated [Insufficient Evidence]
• cardiomyopathy, hypertrophic [Insufficient Evidence]
• cardiovascular disease [Insufficient Evidence]
• cataracts, postop [Insufficient Evidence]
• cerebellar ataxia [Insufficient Evidence]
• CHF [Possibly Effective]
• chronic fatigue syndrome [Insufficient Evidence]
• cocaine dependence [Insufficient Evidence]
• coenzyme Q10 deficiency [Likely Effective]
• COPD [Insufficient Evidence]
• COVID-19 [Insufficient Evidence]
• critical illness (trauma) [Insufficient Evidence]
• cyclic vomiting syndrome [Insufficient Evidence]
• depression [Insufficient Evidence]
• diabetes mellitus [Possibly Ineffective]
• diabetic nephropathy [Insufficient Evidence]
• diabetic neuropathy [Possibly Effective]
• dry eye disease [Insufficient Evidence]
• erectile dysfunction [Insufficient Evidence]
• fatigue [Insufficient Evidence]
• fatigue, chemo-related [Possibly Ineffective]
• fibromyalgia [Possibly Effective]
• Friedreich ataxia [Insufficient Evidence]
• hearing loss [Insufficient Evidence]
• hepatitis C [Insufficient Evidence]
• hepatotoxicity, toxin-induced [Insufficient Evidence]
• HTN [Insufficient Evidence]
• Huntington disease [Likely Ineffective]
• hyperlipidemia [Insufficient Evidence]
• infertility in patients of childbearing potential [Insufficient Evidence]
• ischemic reperfusion injury [Possibly Effective]
• lichen planus [Insufficient Evidence]
• male infertility [Insufficient Evidence]
• maternally inherited diabetes mellitus and deafness [Insufficient Evidence]
• metabolic dysfunction-associated steatotic liver disease [Insufficient Evidence]
• metabolic syndrome [Insufficient Evidence]
• migraine prophylaxis [Possibly Effective]
• mitochondrial myopathies [Insufficient Evidence]
• multiple sclerosis [Possibly Effective]
• muscular dystrophy [Possibly Effective]
• myalgia, statin-induced [Insufficient Evidence]
• myocarditis [Insufficient Evidence]
• myopathy, statin-induced [Insufficient Evidence]
• obesity [Insufficient Evidence]
• Parkinson disease [Possibly Ineffective]
• periodontitis [Insufficient Evidence]
• Peyronie disease [Possibly Effective]
• physical performance [Insufficient Evidence]
• polycystic ovary syndrome [Insufficient Evidence]
• post-polio syndrome [Possibly Ineffective]
• Prader-Willi syndrome [Insufficient Evidence]
• pre-eclampsia [Insufficient Evidence]
• renal failure [Insufficient Evidence]
• schizophrenia [Insufficient Evidence]
• sepsis [Insufficient Evidence]
• tooth extraction [Insufficient Evidence]
• ulcerative colitis [Insufficient Evidence]
• wound healing [Insufficient Evidence]
• wrinkled skin [Insufficient Evidence]
• xerostomia [Insufficient Evidence]